CRO Services for Single-Cell Multiomics Profiling
ID: 75N95025Q00238Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Center for Advancing Translational Sciences (NCATS), is seeking a contract research organization (CRO) to provide services for single-cell multiomics profiling. The primary objective is to conduct Human Discovery Panel (HDP) analysis on 33 human pluripotent stem cell-derived sensory neuron (hPSC-SN) samples to generate single-cell multiomic data that will inform on transcriptomic and proteomic changes during inflammatory sensitization. This procurement is classified under NAICS code 541714 and is intended as a sole-source contract to Proteintech Group, Inc., which possesses the unique capabilities required for this analysis. Interested parties may submit capability statements to contest the sole-source determination. For further inquiries, contact Andrew Varley at andrew.varley@nih.gov or 301-827-5851, or Joshua T. Lazarus at Josh.Lazarus@nih.gov or 301-827-6923.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Center for Advancing Translational Sciences (NCATS) intends to award a sole-source contract to Proteintech Group, Inc. for "CRO Services for Single-Cell Multiomics Profiling." This non-competitive procurement, classified under NAICS code 541714 (Research and Development in Biotechnology), is authorized by FAR Part 13 for simplified acquisitions. NCATS requires a contract research organization (CRO) to perform Human Discovery Panel (HDP) analysis on 33 hPSC-SN samples under inflammatory conditions, providing single-cell multiomic data. Proteintech Group, Inc. was selected because its HDP platform is deemed the only one capable of combining single-cell RNA sequencing with DNA barcoded antibodies targeting up to 325 distinct proteins specific to the required samples. This notice is not a request for competitive proposals, but interested parties may submit capability statements to challenge the sole-source determination.
    NIDA, on behalf of NCATS, issued a Sources Sought Notice (Solicitation Number: 75N95025Q00238) for Human Discovery Panel (HDP) analysis services. The purpose is to gather information on qualified small businesses capable of performing single-cell multiomic data analysis to inform NCATS on transcriptomic and proteomic alterations during inflammatory sensitization in human pluripotent stem cell-derived sensory neurons (hPSC-SNs). The selected contractor will analyze 33 samples, providing single-cell RNA sequencing and DNA barcoded antibody analysis targeting up to 325 distinct proteins. Interested vendors must submit capability statements by August 12, 2025, detailing their technical abilities, personnel qualifications, company information (including NAICS 541380), and any relevant government contracts. This notice is for information gathering only and does not constitute a solicitation for proposals.
    Similar Opportunities
    A--Pre-Sol Notice of Intent
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), has issued a Pre-Solicitation Notice of Intent regarding upcoming procurement opportunities. This notice pertains to research and development services in the physical, engineering, and life sciences sectors, as indicated by the NAICS code 541715. The services sought are crucial for advancing health-related research and healthcare services, contributing to the overall mission of the NIH. For further inquiries, interested parties can contact Lynn M. Furtaw at lynn.furtaw@nih.gov or by phone at +1 301 435 0330.
    Biospecimen Core Resource
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) under the National Cancer Institute (NCI), is seeking to establish a Biospecimen Core Resource (BCR) to support various biospecimen-related activities. The BCR will operate under documented Standard Operating Procedures (SOPs) to facilitate the collection, processing, distribution, and storage of biospecimens as outlined in NCI Task Orders. This initiative is crucial for advancing cancer research and ensuring the integrity and availability of biospecimens for scientific studies. Interested parties can reach out to Apisit Viriya at apisit.viriya@nih.gov or Mataya Robinson at mataya.robinson@nih.gov for further details regarding this opportunity.
    A--Biologic Specimen and Data Repositories Information Coordinating Center (BioLIN
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information regarding the Biologic Specimen and Data Repositories Information Coordinating Center (BioLINCC). This opportunity aims to gather insights on the capabilities and qualifications of potential contractors who can support the management and coordination of biologic specimen and data repositories. The services are critical for advancing health research and ensuring the integrity and accessibility of biological data for various studies. Interested parties can reach out to Natalie E. Bruning at natalie.bruning@nih.gov or by phone at +1 301 827 7528 for further details regarding this sources sought notice.
    Notice of Intent to Sole Source – America’s Staffing Partner
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), has issued a Notice of Intent to award a sole source bridge contract to America’s Staffing Partner for medical assistant staffing support. This contract is essential to maintain adequate coverage of nursing staff in the Clinical Center Nursing Department until the completion of a competitive contract selection process, which is expected to finalize in 2026, as the current contract expires on December 14, 2025. The procurement will utilize Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for streamlined processes for acquisitions not exceeding $9 million, and exempting it from standard competition requirements. Interested parties may submit comments regarding this notice to Ryssa Nix, Contract Specialist, at Ryssa.nix@nih.gov by December 12, 2025, at 12 PM EST.
    Notice of Intent to Sole Source 2 sets of QX200 ddPCR Systems
    Buyer not available
    The National Institutes of Health (NIH), specifically the Clinical Center (CC), intends to negotiate a sole-source contract for the renewal of maintenance services for two QX200 AutoDG ddPCR Systems from Bio-Rad Laboratories. This five-year service contract, valued at $151,494, is essential for the ongoing maintenance and support of these systems, which are critical for droplet digital PCR (ddPCR) vector copy number detection and gene modification efficiency testing on clinical cellular products. The contract ensures compliance with FDA regulations and is vital for patient care testing, as failure to secure these services could adversely affect patient safety. Interested parties may submit capability statements by December 18, 2025, to valerie.gregorio@nih.gov, referencing NOI-CC-26-000112.
    EZ1 & 2 DNA Blood Isolation Kit and DNA Tissue Kit
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole source contract with Qiagen for the procurement of EZ1 & 2 DNA Blood Isolation Kits and DNA Tissue Kits. These kits are critical for the ongoing clinical research and patient care at the NIH Clinical Center, particularly for Human Leukocyte Antigen (HLA) matching in transplant patients and potential donors. The kits have been extensively tested and are essential for providing high-quality DNA samples necessary for critical Next Generation Sequencing, with an estimated contract value of $29,166.25. Interested parties may submit capability statements by email to valerie.gregorio@nih.gov by 11:00 AM EST on December 13, 2025, referencing NOI-CC-26-000013.
    Preventative Maintenance Agreement for 36 Heracell Vios 160i CO2 incubators
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health (NIH), intends to award a firm-fixed-price contract to Thermo Fisher Scientific for a preventative maintenance agreement covering 36 HERA VIOS 160i CO2 incubators. This sole-source acquisition is essential for maintaining critical equipment used in the manufacturing of cell-based therapies, as mandated by the FDA's regulations on controlled maintenance of such equipment. The estimated cost for this project is $55,311.32, and it is crucial for ensuring the continuous, compliant operation of equipment vital for patient care. Interested parties may submit capability statements by email to valerie.gregorio@nih.gov by 11:00 AM EST on December 18, 2025, referencing the notice of intent (NOI-CC-26-000054).
    Support for Evaluating and Conducting Computational and Alternative Toxicological Methods for the National Institute of Environmental Health Sciences
    Buyer not available
    The Department of Health and Human Services, specifically the National Institute of Environmental Health Sciences (NIEHS), is seeking proposals from small businesses to support the evaluation and conduct of computational and alternative toxicological methods. The objective of this procurement is to assist NIEHS in chemical hazard and risk assessment while minimizing the use of animal testing, focusing on areas such as population variability, developmental neurotoxicity, and carcinogenicity. This contract, which is a Cost-Plus-Fixed-Fee type, has a base period of performance from June 1, 2026, to May 31, 2027, with nine additional one-year options and a potential six-month extension. Proposals are due by December 19, 2025, and must be submitted electronically via the NIH eCPS website; interested parties can contact Jason Williams at jason.williams2@nih.gov or Lisa Schaupp at lisa.schaupp@nih.gov for further information.
    R--Repository for Osteoarthritis Initiative
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking repository services for the Osteoarthritis Initiative. The primary objective of this procurement is to engage services for the archiving, storage, maintenance, and retrieval of biological specimens associated with the initiative sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This acquisition is crucial for ensuring the integrity and accessibility of valuable biological data that supports ongoing research in osteoarthritis. Interested parties can reach out to Derek Bowks at derek.bowks@nih.gov for further information regarding this opportunity.
    Operation and Maintenance of a Murine Pathogen-Free Mouse Breeding Facility
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking contractors for the operation and maintenance of a Murine Pathogen-Free Mouse Breeding Facility. This procurement aims to ensure the facility operates efficiently, providing essential support for research involving pathogen-free mice, which are critical for various biomedical studies. The contract will be managed under the PSC code R707, indicating a focus on management and support services. Interested parties can reach out to Sevag Kasparian at Sevag.Kasparian@nih.gov or 240-669-5177, or Gabriel Contreras at gabriel.contreras@nih.gov or 240-292-4828 for further details regarding the opportunity.